Dow Up0.25% Nasdaq Up0.65%

Regulus Therapeutics Inc. (RGLS)

-NGM
5.80 Up 0.03(0.52%) May 27, 4:00PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Net Income (21,207) (7,226) (13,000) (21,035)
Operating Activities, Cash Flows Provided By or Used In
Depreciation617  756  708  780  
Adjustments To Net Income3,749  3,786  2,652  5,875  
Changes In Accounts Receivables9,959  (9,696) -  2,419  
Changes In Liabilities(1,360)(490)(1,126)1,511  
Changes In Inventories -   -   -   -  
Changes In Other Operating Activities(688)(4,174)(1,034)687  
Total Cash Flow From Operating Activities (8,930) (17,044) (11,800) (9,763)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(395)(490)(463)(174)
Investments12,097  13,558  5,983  10,511  
Other Cash flows from Investing Activities(11)(27)(21)(12)
Total Cash Flows From Investing Activities 11,691   13,041   5,499   10,325  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock569  1,679  3,581  960  
Net Borrowings(41)(40)(40)(38)
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities 528   1,639   3,541   922  
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents 3,289   (2,364) (2,760) 1,484  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.